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Abstract
Context: Sepsis is one of the most common causes of neonatal mortality, especially in developing countries. The purpose of this
study was to systematically review the bacterial causative agents of neonatal sepsis and their antibiotic susceptibility in Iran.
Material and Methods: We searched all previously published papers to gather related information on Iranian neonatal sepsis in
international and national databases (in both Persian and English) from 2006 to 2018. The standard STROBE checklist was used for
quality assessment. The data were analyzed by statistical methods with a random-effects model using Stata 14 software.
Results: A total of 89,472 neonates with sepsis (presented in 17 studies) were included in this systematic review. The mortality rate of
neonates was 28.0%. The proportions of neonatal sepsis caused by Gram-negative and Gram-positive bacteria were 66.0% and 33.0%,
respectively. The most common bacteria causing neonatal sepsis were Klebsiella pneumoniae and Pseudomonas aeruginosa (Gram-
negative) and coagulase-negative staphylococci and Staphylococcus aureus (Gram-positive).
Conclusions: Gram-negative bacteria are the most common causes of neonatal sepsis in Iran. Imipenem is the most effective an-
tibiotic against Gram-negative bacilli and vancomycin against Gram-positive cocci causing neonatal sepsis in Iran.
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1. Context
Sepsis is a systemic inflammatory response to infection
in which microorganisms entering the bloodstream cause
severe symptoms such as fever and shock (1). This disease
is one of the most important causes of neonatal mortal-
ity, especially in premature newborns (2, 3). The prevalence
of this disease is one to eight per 1000 newborns in devel-
oped countries (4), while this rate is quite higher in poor
and developing countries. Therefore, sepsis is still among
the most common causes of newborn death in developing
countries (5).
Sepsis in younger than four-week-old newborns is diag-
nosed by clinical signs and positive bacterial blood culture.
There are two types of sepsis based on the age of newborns
when the symptoms appear, including early-onset sepsis
and late-onset sepsis. Early-onset septicemia occurs shortly
after birth by the organisms found in the maternal birth
canal. Late-onset sepsis occurs 48 hours after the birth of
neonates with the progression of clinical signs. The peak
incidence for late-onset sepsis is usually around a week af-
ter birth, and it is usually caused by newborns’ exposure
to environmental microorganisms (4). In various studies
in Iran, the incidence rate of sepsis has been reported from
16.6 to 24.65% (6).
Bacteria are of the most important causes of neona-
tal sepsis. Many studies have shown group B Strepto-
cocci, coagulase-negative staphylococci (CoNS), Staphylo-
coccus aureus, Escherichia coli, Klebsiella, Enterobacter, Pseu-
domonas aeruginosa, and Enterococci as the most common
bacterial agents causing neonatal sepsis (7-10). Several fac-
tors in the prenatal and postnatal periods can be involved
in neonatal sepsis, such as the type of delivery, preterm
birth, premature rupture of the fetal membrane, uterine
inertia, and maternal infection. Furthermore, sepsis is
more likely to occur in premature, low-birth-weight, and
male neonates (11).
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The common signs and symptoms of sepsis in new-
borns are usually non-specific. A delay in the treatment of
neonatal sepsis is mostly associated with a higher mortal-
ity rate. Therefore, antibiotic therapy should quickly begin
for newborns before reporting laboratory results. Given a
variety of microorganisms causing neonatal sepsis in dif-
ferent regions, choosing appropriate antibiotics for empir-
ical therapy depends on the epidemiological information
of common circulating organisms and their susceptibility
patterns in each area (12). Although there are few studies
on bacterial agents causing sepsis in neonates in different
parts of Iran, currently, there is no comprehensive inves-
tigation or systematic review on this topic. Therefore, the
purpose of this study was to systematically review the bac-
terial agents causing neonatal sepsis and their antibiotic
susceptibility in Iran.
2. Material and Methods
The present study was carried out by reviewing arti-
cles on neonatal bacterial sepsis in Neonatal Intensive Care
units (NICUs) in Iran from 2006 to 2018. We searched sev-
eral English keywords and their Persian equivalent includ-
ing “neonatal septicemia”, “neonatal sepsis”, “antibiotic re-
sistance in neonatal sepsis”, “neonatal blood infections”,
and “bacterial agents of neonatal sepsis” in the title and ab-
stract of published articles in various databases, including
MEDLINE, EMBASE, Scopus, ISI, Google Scholar, MD Consult,
BMJ Journals, Cochrane Library, Directory of Open Access
Journals (DOAJ), BioMed Central, OvidSP, Oxford Journals,
ProQuest, Ebscohost, and Emerald Journals, as well as Ira-
nian databases such as SID, IranDoc, Iranmedex, Scimed,
and RICeST. All published papers from 2006 to 2018 in-
dexed in these databases were reviewed. To restrict the
results to Iran, all the aforementioned keywords were ap-
plied with “AND Iran”.
After creating a list of titles and abstracts of retrieved
studies, the standard STROBE checklist was used to deter-
mine the quality of the studies. The STROBE checklist con-
sists of 22 different sections that evaluate the various as-
pects of the methodology, including sampling method,
statistical analysis, adjustment of confounders, measuring
variables, the validity and reliability of tools, and the objec-
tives of the study. In this study, an inclusion criterion was
having a score of at least 15 on the 22 sections of the STROBE
checklist. Accordingly, 88 articles were selected out of 280
primary retrieved articles. After the comprehensive exami-
nation of the articles, 17 articles were selected that were the
most relevant studies to our objectives (Figure 1). The qual-
ity of the articles was checked by two researchers (AA and
RCH) independently.
 
Number of 
primarily found 
articles: 280 
88 articles were 
selected 
25 articles were 
selected 
17 final articles 
were selected 
8 items were deleted 
due to poor quality 
of the contents 
63 articles were 
deleted due to low 
relevance abstracts 
192 articles were 
deleted due to 
inappropriate titles 
Figure 1. The flowchart of the selection steps of articles
Other inclusion criteria included studies that (1) were
done on an Iranian population; (2) were performed during
the last 12 years (2006 - 2018); (3) included bacterial agents
causing neonatal sepsis; (4) conducted antibiotic suscepti-
bility testing of bacterial isolates; and (5) measured the an-
tibiotic resistance level by a standard method. The exclu-
sion criteria included studies that (1) were available only
in the abstract; (2) were review articles; (3) were Persian-
language articles if their English language versions were
also available (i.e., only the English version of articles were
used); (4) were case studies; and (5) determined bacterial
agents without antibiotic susceptibility testing.
The data for bacterial causative agents of sepsis and
their antibiotic susceptibility were extracted from all
neonatal cases of each study. Subsequently, the frequency
of associated parameters of all studies was also was used
to better estimate these criteria. Thus, the percentage of
bacterial agents in 17 studies was calculated as an average
number. Furthermore, the antibiotic susceptibility results
of bacteria were extracted from studies, and the sensitivity
of each bacterium to each antibiotic was determined and
expressed as the mean± standard deviation.
The characteristics of each study were recorded for
data analysis, including the authors’ names, publication
year, study location, patient numbers and gender, neona-
tal weight and age, type of delivery, the mortality rate of
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newborns, bacterial agents, and antibiotic resistance rates.
All data were presented in tables or figures. The hetero-
geneity among studies was checked using the chi-square
test and quantified using the I2 index. All analyses were
done using a random-effects model with a 95% confidence
interval by Stata 14 statistical software (Stata Corp., College
Station, TX, USA). Finally, the data were interpreted by con-
sidering the results of other studies from several countries.
3. Results
Table 1 shows the general data of all 17 studies. A total
of 89,472 neonates with sepsis had been assessed in the 17
selected articles. Only 12 articles (with 75,336 neonates) re-
ported the gender of the neonates in which 40.99± 12.35%
of the neonates were female, and 59± 11.92% of them were
male (Figure 2). The average age of the neonates in eight
studies, with 875 neonates, was less than three days, three
to seven days, and more than seven days for 211 (28.3%), 294
(31.9%), and 370 (39.8%) neonates, respectively. The distribu-
tion of studies based on Iran regional locations was 29.4%
in the West, 5.8% in the East, 11.7% in the North, 5.8% in the
South, 41.1% in the Center, and 5.8% in the Northwest.
The pooled proportion for neonatal sepsis prevalence
in Iran was 14% (95% CI = 0.10, 0.18) with a significant het-
erogeneity (I2 = 99.42%, P < 0.001). The proportions were
13%, 18%, 15%, 12%, 15%, and 14% in the Center, East, North,
Northwest, South, and West of Iran, respectively (Figure 3).
The pooled proportion of early and late-onset neonatal
sepsis in Iran was 50% (95% CI = 37.0, 63.0) with a signifi-
cant heterogeneity (I2 = 95.6%, P < 0.001). The proportions
were 56% and 44% for the early and late sepsis, respectively
(Figure 4).
Klebsiella pneumoniae (24.2± 29.33%) and Pseudomonas
aeruginosa (16.6 ± 11.91%) were the most common Gram-
negative bacteria causing neonatal sepsis in Iran. On
the other hand, coagulase-negative staphylococci (15.17
± 19.6%) and Staphylococcus aureus (8.41 ± 10.51%) were
the most common Gram-positive bacteria isolated from
neonatal sepsis in Iran (Figure 5). The overall antibiotic sus-
ceptibility results of Gram-negative and Gram-positive bac-
teria are presented in Tables 2 and 3, respectively.
The proportions of Gram-negative and Gram-positive
bacteria causing neonatal sepsis were 66.0% and 33.0%,
respectively, with considerable evidence of heterogene-
ity (Gram-negative bacteria: I2 = 98.9%, P > 0.001; Gram-
positive bacteria: I2 = 98.7%, P > 0.001). The estimated mor-
tality rate of neonates was 28.0% (95% CI = 10.0, 46.0) (Fig-
ure 6).
4. Discussion
Sepsis is one of the most serious infectious diseases of
neonates (1). Due to the small number of studies and lack
of their proper distribution in the geographical areas of
Iran, it is not conceivable to compare the rates of neona-
tal sepsis in different regions of the country. In a review
of eight studies on neonatal sepsis from India, USA, Thai-
land, South Korea, Myanmar, and Guatemala, the lowest
prevalence was in the USA with 450 cases in 100,000 births
while the highest prevalence was in India with 17,000 cases
in 100,000 births. Furthermore, the overall prevalence
of neonatal sepsis was reported as 2,202 cases in 100,000
births in seven countries (28). The reason for the differ-
ence in the sepsis prevalence in various parts of the world
may be the factors such as socioeconomic status, quality of
health care, climatic conditions, race, the level of technol-
ogy, and medical knowledge (29).
Studies in different parts of the world suggest that
male neonates are more susceptible to bacterial sepsis
than females so that the risk of sepsis is twofold higher in
males (29-31), which is consistent with our results. This sex-
dependent vulnerability is probably related to sex-linked
factors in male neonates (29, 30). Given the relationship be-
tween sepsis frequency and neonatal weight, in our study,
neonates with less than 2 kg weight showed a higher rate
of sepsis, suggesting that low-birth-weight is an important
factor in the development of sepsis, which is consistent
with the literature review (31). Moreover, similar to the pre-
vious research (9), the majority of sepsis cases in our study
were early-onset sepsis, indicating the importance of ma-
ternal factors and maternal health status in neonatal sep-
sis.
Regarding the frequency of isolated bacteria in our
study, Gram-negative bacilli including K. pneumoniae and
P. aeruginosa were the most common causes of neonatal
sepsis in Iranian neonates. In a study carried out in Tehran
(the capital of Iran), the most common cause of sepsis was
K. pneumonia (32). In a study from India, K. pneumonia and
P. aeruginosa were the most common causes of neonatal
sepsis (7), which is similar to our results. On the other
hand, in a study from Iran, P. aeruginosa and coagulase-
negative staphylococci were the most common causes of
neonatal sepsis (33). Furthermore, in a study from the USA,
coagulase-negative staphylococci, S. aureus, andK. pneumo-
niaewere the most common bacteria causing neonatal sep-
sis (34). In a review article in Nigeria from 1987 to 2017, S.
aureus and K. pneumonia were reported as the most com-
mon agents of neonatal sepsis (35). These differences in the
frequency of bacterial agents of neonatal sepsis in various
regions can be explained by differences in socioeconomic
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Table 1. General Data on Neonatal Sepsis From 17 Studiesa
Authors’
Name
Regional
Location of
the Study in
Iran
Year of Study Number of
Neonates
Number of
Neonatal
Sepsis, %
Year of
Publication
Hospital
Ward
Prospective
(P)/Retrospective
(R) Study
Reference
Mohammadi
et al.
East 2006 175 32 (18.2) 2007 NICU p (13)
Qrbany et al. North 2007 298 31 (10.4) 2008 Neonatal Ward R (14)
Marzban et al. Center 2007 124 12 (9.6) 2010 NICU R (15)
Dezfoolimanesh
et al.
West 2008 2175 90 (4.13) 2011 NICU R (16)
Karambin
and Zarkesh
Center 2008 - 2010 611 64 (10.6) 2011 Neonatal Ward P (17)
Ghasemi et al. West 2014 - 2015 78 17 (21.9) 2018 NICU P (18)
Nikkhoo et al. West 2010 472 30 (6.4) 2015 NICU P (19)
Rajabi and
Soltan Dallal
Center 2012 120 20 (16.6) 2012 NICU P (20)
Yazdi et al. Center 2012 216 55 (25.4) 2014 Neonatal Ward P (4)
Esmaeili et al. West 2012 1897 563 (29.4) 2014 Neonatal Ward P (21)
Rafati et al. North 2013 100 20 (20) 2014 Neonatal Ward P (11)
Ebrahim-
Saraie et
al.
South 2011 - 2013 491 74 (15.1) 2016 Neonatal Ward R (22)
Mahallei et al. Northwest 2015 - 2016 838 102 (12.1) 2018 NICU R (23)
Maham et al. Center 2014 - 2016 2054 433 (21.1) 2018 Neonatal Ward R (24)
Mahmoudi et
al.
Center 2011 - 2016 68233 2325 (3.4) 2017 Neonatal Ward R (25)
Rabirad et al. Center 2010 - 2011 11446 910 (7.95) 2014 Neonatal Ward P (26)
Nikpay et al. West 2012 - 2017 144 15 (10.4) 2018 Neonatal Ward R (27)
aValues are expressed as No. (%).
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Figure 2. The frequency of sepsis based on patient gender
status, quality of health care, climatic conditions, race, the
level of technology, and medical knowledge.
Our results indicated that the most common
Gram-negative bacterial isolates (K. pneumoniae and
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Figure 3. The pooled proportion of neonatal sepsis in Iran
Pseudomonas aeruginosa) were mostly susceptible to
imipenem, suggesting this antibiotic as a good choice
for empirical therapy. This is supported by the results of
another study from Iran (7). The most common Gram-
positive bacteria of neonatal sepsis were susceptible to
vancomycin, which is consistent with the results of other
studies (36, 37).
Here, we should declare some limitations to our study.
We lacked relevant information to assess the relationship
between neonatal weight, age, gender, and the type of
childbirth and mortality rates for sepsis in several articles
used in this study. Further, it is notable that all studies
Arch Pediatr Infect Dis. 2020; 8(2):e92212. 5
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Figure 4. The pooled proportion of early and late neonatal sepsis in Iran
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Figure 5. The frequency of bacteria causing neonatal sepsis in Iranian neonates. The numbers above each bar show the frequency percentage of each bacterium.
had used the disc diffusion method for evaluating the an-
tibiotic susceptibility of bacteria, which is not appropri-
ate for some types of antibiotics against particular bacte-
ria. Some fastidious bacteria, which are among the com-
mon agents of neonatal sepsis such as Streptococcus, were
not isolated in the selected studies. the survivors of a sep-
sis episode may be readmitted to the hospital again for sep-
sis (38). Here, no or little information was found on the re-
peated sepsis episodes in the included articles. Therefore,
we did not consider this information for analysis in this
6 Arch Pediatr Infect Dis. 2020; 8(2):e92212.
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Table 2. The Pooled Proportion of Antibiotic Resistance of Common Gram-Negative Bacteria Causing Neonatal Sepsis in Iran
Antibiotics Klebsiella pneumonia, Pr (95% CI) Escherichia coli, Pr (95% CI) Pseudomonas aeruginosa, Pr (95% CI) Enterobacter, Pr (95% CI)
Imipenem 0.13 (0.07, 0.19) 0.15 (0.10, 0.20) 0.21 (0.21, 0.22) 0.27 (0.07, 0.46)
Ciprofloxacine 0.13(0.11, 0.14) 0.36 (0.34, 0.39) 0.98 (0.98, 0.98) 0.08 (0.07, 0.09)
Ampicilin 0.83(0.66-1.00) 0.78 (0.74, 0.82) 0.27 (0.27, 0.28) 0.77 (0.45, 1.10)
Tobramycin 0.18 (0.17, 0.20) 0.06 (0.05, 0.07) 0.09 (0.09, 0.10) -
Gentamicin 0.49 (0.39, 0.60) 0.38 (0.30, 0.46) 0.40 (0.11, 0.70) 0.42 (0.20, 0.64)
Amikacin 0.42 (0.15, 0.69) 0.25 (0.20, 0.29) 0.30 (0.20, 0.40) 0.48 (0.25, 0.70)
Chloramphenicol 0.52 (0.43, 0.61) 0.68 (0.35, 1.00) 0.65 (0.60, 0.70) -
Cefotaxime 0.58 (0.36, 0.80) 0.54 (0.37, 0.71) 0.49 (0.47, 0.50) 0.60 (0.47, 0.72)
Ceftriaxone 0.26 (0.24, 0.28) 0.32 (0.09, 0.56) 0.19 (0.19, 0.19) 0.19 (0.18, 0.21)
Ceftazidime 0.81 (0.80, 0.81) 0.54 (0.45, 0.63) 0.29 (0.24, 0.34) 0.50 (0.50, 0.50)
Ceftizoxime 0.20 (0.14, 0.27) 0.37 (0.33, 0.41) - -
Cefixime 0.74 (0.72, 0.76) 0.54 (0.15, 0.92) 0.52 (0.51, 0.52) 0.56 (0.54, 0.58)
Cotrimoxazole 0.55 (0.47, 0.64) 0.63 (0.56, 0.70) 0.20 (0.20, 0.21) 0.33 (0.15, 0.52)
Cefalotin - 0.67 (0.62, 0.71) - 0.88 (0.84, 0.90)
Overall 0.49 (0.40, 0.58) 0.45 (0.35, 0.56) 0.39 (0.24, 0.54) 0.47 (0.31, 0.62)
Table 3. The Pooled Proportion of Antibiotic Resistance of Common Gram-Positive Bacteria Causing Neonatal Sepsis in Iran
Antibiotics Staphylococcus aureus, Pr (95% CI) Staphylococcus epidermidis, Pr (95%
CI)
Coagulase-Negative Staphylococci,
Pr (95% CI)
Vancomycin 0 0 0
Ampicilin 0.89 (0.89, 0.90) 0.75 (0.74, 0.76) 0.82 (0.80, 0.84)
Oxacillin - 0.53 (0.50, 0.56) -
Gentamicin 0.38 (0.20, 0.57) 0.41 (0.14, 0.69) 0.35 (0.25, 0.45)
Amikacin 0.37 (-0.06, 0.80) 0.12 (0.11, 0.14) 0.28 (0.26, 0.31)
Tobramycin 0.44 (0.42, 0.47) - -
Cefotaxime - 0.60 (0.55, 0.64) 0.40 (0.37, 0.43)
Ceftriaxone 0.05 (0.02, 0.11) 0.04 (0.03, 0.05) -
Ceftizoxime - 0.25 (0.19, 0.32) 0.25 (0.19, 0.32)
Cefixime - 0.40 (0.36, 0.45) -
Ciprofloxacine 0.37 (0.36, 0.37) 0.78 (0.75, 0.80) 0.34 (0.32, 0.36)
Cotrimoxazole 0.65 (0.53, 0.77) 0.53 (0.14, 0.91) 0.74 (0.72, 0.76)
Chloramphenicol 0.26 (0.24, 0.28) 0.27 (0.25, 0.28) -
Cefalotin 0.88 (0.87, 0.90) 0.25 (0.21, 0.29) -
Overall 0.49 (0.35, 0.62) 0.44 (0.28, 0.60) 0.42 (0.26, 0.58)
study, which may produce bias as a limitation of this study.
5. Conclusions
The prevalence of sepsis is still high in NICUs and
neonatal wards of hospitals in Iran. Low-birth-weight and
male gender are among the risk factors of neonatal sep-
sis in Iran. Gram-negative bacteria, including K. pneumonia
and P. aeruginosa, are the most common bacterial agents
of neonatal sepsis with good susceptibility to imipenem.
Coagulase-negative staphylococci and S. aureus are com-
mon Gram-positive bacteria and vancomycin is the most
effective drug for them. It seems that further studies of
neonatal sepsis are required to more accurately determine
maternal and neonatal risk factors and bacterial agents
with their susceptibility to available antibiotics.
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Figure 6. The pooled proportion of Gram-negative and Gram-positive bacteria causing neonatal sepsis
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